YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Comprehensive Bioinformatical Analysis of Association of Igfl2 Expression and Methylation Profiles With Prognosis of Head and Neck Cancer

dc.authorscopusid 55910152400
dc.authorscopusid 59546529100
dc.contributor.author Görgişen, G.
dc.contributor.author Yabalak, S.
dc.date.accessioned 2025-05-10T16:56:06Z
dc.date.available 2025-05-10T16:56:06Z
dc.date.issued 2025
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Görgişen G., Van Yuzuncu Yil University, Faculty of Medicine, Department of Medical Genetics, Van, Türkiye; Yabalak S., Van Yuzuncu Yil University, Faculty of Medicine, Department of Medical Genetics, Van, Türkiye en_US
dc.description.abstract Insulin-like growth factor like (IGFL) family is a gene family that contains 11 cysteine residues, including two CC mo tifs, and has structural homology with Insulin like Growth Factor (IGF) family. Expression of IGFL genes has been detected in various tissues, including fetal skin, spinal cord, cerebellum, placenta, spleen, stomach, testis, and fetal heart. The biological functions and gene interactions of IGFL molecules have not yet been fully elucidated, but they are thought to perform similar functions to IGFs due to their structural similarities with the IGF family. Therefore, it is aimed to determined the relationship between IGFL2 expression and Head and Neck Cancer (HNSC) through bioinformatical approaches. GEPIA2, UALCAN, OncoDB, Mexpress, Cancersea and Kaplan-Meier Plotter databases were used for bioinformatical analyses. Our results showed that expression of IGFL2 increased in tumor tissues especially early stages of HNSC. In addition, we detected that promotor methylation status of IGFL2 decreased in tumor tissues. Gene correlation analyses also showed that IGFL2 expression is positively correlated with gene produ cts that are responsible for the development of HNSC such as IRS1, EGFR, CDK6. As a result, IGFL2 induces tumorigenesis in early stages of HNSC and may be used as a prognostic factor in the development of HNSC. © 2025, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2025.54531
dc.identifier.endpage 28 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-85217161866
dc.identifier.scopusquality Q4
dc.identifier.startpage 22 en_US
dc.identifier.uri https://doi.org/10.5505/ejm.2025.54531
dc.identifier.uri https://hdl.handle.net/20.500.14720/3559
dc.identifier.volume 30 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Hnsc en_US
dc.subject Igfl2 en_US
dc.subject Pan-Cancer en_US
dc.title Comprehensive Bioinformatical Analysis of Association of Igfl2 Expression and Methylation Profiles With Prognosis of Head and Neck Cancer en_US
dc.type Article en_US

Files